Introduction

Although the term ‘genetic counselling’ was coined by Sheldon Reed in 1947,1 the genetic counselling profession is relatively young in comparison with medicine and nursing. Although genetic counselling can be undertaken by trained professionals from a range of disciplines, those describing themselves as genetic counsellors are specifically trained for the work. A definition of genetic counselling as an activity was produced by the NSGC Taskforce in 2006 and states that ‘genetic counselling is the process of helping people understand and adapt to the medical, psychological and familial implications of the genetic contributions to disease. The process includes interpretation, risk assessment, education and counselling.2 However, the members of that Task Force deliberately sought to define the activity, rather than the professional role of genetic counsellors. In Europe, the Ad Hoc Genetic Nurse and Counsellor Committee of the European Society of Human Genetics (ESHG) suggested that ‘genetic counsellor’ should be a protected professional title referring to a health professional who had been educated and trained at Master’s level to enable them to develop the core competence defined for the role and to practice according to the Code of Ethics.3 This definition has been adopted by the European Board of Medical Genetics, which is responsible for registration of genetic counsellors in Europe.4 The key aspects of the role of the European genetic counsellor are presented in Figure 1.

Figure 1
figure 1

Role of the genetic counsellor.

Genetic counsellors may be employed in specialist genetic centres or within other specialist units. Frequently they contribute to patient care as one member of a multi-disciplinary team, for example, in oncology,5 ophthalmology,6 cardiology,7 metabolic clinics8 or obstetrics.9 The roles of the genetic counsellor (Figure 1) include both information giving and exploration of the client’s circumstances and needs.3 However, it is not clear whether genetic counsellors fulfil all of the roles ascribed to them, in either specialist genetic clinics or in more mainstream health-care settings. For example, there has long been discussion around whether genetic counsellors adhere to a teaching or counselling model of practice. The ‘teaching model’ relies far more on information provision to support decision making than exploration of the client’s emotional and social needs, whereas use of the ‘counselling model’ may enhance the exploration of the context of decisions to be made and support adaptation to risk or diagnosis. It could be argued that use of the teaching model reinforces the position of the counsellor as expert; however, those who adhere to this model see information as empowering to clients, whereas those using the counselling model emphasise the relationship between client and counsellor and positive regard for the client as being the tools of empowerment. Meiser et al10 undertook a systematic review of studies that involved analysis of actual genetic counselling sessions by genetic health-care providers, including genetic counsellors. The authors concluded that the teaching model appeared to predominate, with counsellors spending much more time speaking during the consultation than clients. However, more positive outcomes for clients were associated with those consultations in which clients were given more opportunities to speak and the counsellor was less dominant. It therefore appears that both information provision and sensitive counselling are required to fulfil the role appropriately and maximise benefit to patients.

In order to evaluate the extent to which genetic counsellors fulfil the roles adopted by the European Board of Medical Genetics, we conducted a systematic review of the published relevant scientific evidence.

Materials and methods

Conducting a systematic review enables the evidence on a particular topic to be gathered, analysed and synthesised. Adherence to a rigorous set of guidelines is essential to ensure rigour and objectivity. We followed the process for systematic reviews developed by the Centre for Reviews and Dissemination,11 which involves identification of relevant search terms, selection of studies based on explicit inclusion and exclusion criteria and quality assessment of papers. The research question was ‘What is the role of the genetic counsellor?’.

Search strategy

We initially conducted a search of five relevant electronic databases: Medline, CINAHL, SocIndex, AMED and PsychInfo. Following an initial ad hoc search to determine the relevant search terms, we used the following search terms: ‘genetic counsellor’ or ‘genetic counsellor’ and ‘role’ or ‘task’ or ‘responsibility’ or activity’ or ‘job’ or ‘profession’ and ‘service’ or ‘clinic’ or ‘hospital’ or ‘community’ (within any part of the text). The search focussed on papers published in English between 1 January 2000 and 30 June 2013 and the search was limited to published articles. Papers were eligible for inclusion if they: (i) were based on research using qualitative, quantitative or mixed methods designs, (ii) included data on roles or clinical responsibilities of genetic counsellors (where the paper reported roles of multiple professions, they were included if data related to genetic counsellors could be extracted from data on other professions) and (iii) focussed on the role of the genetic counsellor in specialist genetic or other clinical settings in any country.

Papers were excluded if they: (i) focussed on patient perceptions of the service, rather than analysis of the genetic counsellor role, (ii) related to comparison of delivery modes for genetic counselling, for example, telephone versus face to face counselling, (iii) related to styles of counselling rather than roles or (iv) were focussed on genetic counsellor education.

As a result of the initial search, we identified 419 potential papers for inclusion. Of these, 63 were duplicates, leaving 356 papers for examination. Further to this process, a handsearch of the indexes of four highly relevant journals for papers published between the relevant dates was undertaken, these were: Journal of Genetic Counseling, American Journal of Medical Genetics, European Journal of Human Genetics and Clinical Genetics. No further papers were identified. After reading the titles of all papers, a further 299 were excluded, leaving a total of 57 papers. The abstracts of these papers were read by two researchers, and a further 40 were excluded on the grounds that they did not fit the exclusion criteria (see Figure 2). All 17 remaining papers were read in full by two researchers, of these seven fitted the criteria for the review. This process is illustrated in the PRISMA flow diagram in Figure 2.

Figure 2
figure 2

PRISMA flow diagram demonstrating selection of papers.

Quality assessment

Assessment of the quality of studies was undertaken using the tool developed by Kmet et al.12 This tool facilitates evaluation of both quantitative and qualitative studies, using two lists of relevant questions. Each paper is scored against each question, a score of 2 is assigned if the quality criterion is met, 1 if partially met and 0 if not met. The total score is then converted to a percentage. Each paper was assessed independently by two researchers and any areas of disagreement were discussed until consensus was reached. The tool developers12 do not specify a cutoff point below which papers should be discarded; we decided that a cutoff point of 60% was appropriate to enable us to exclude poor-quality papers. The range of scores for the included papers was 60–89%, therefore all were included.

Data abstraction

Original data from the included studies were abstracted and presented in a table. As there was a diversity of studies and populations, a meta-analysis of the data was not feasible. We therefore conducted a thematic analysis of the data13 and present this in narrative form. At least two of the authors were involved in data selection and abstraction at every stage in the review.

Results

Original data from the included studies are presented in Table 1. Of the seven studies, three were conducted in the United States, three in Australia and one in South Africa. Two studies were undertaken using qualitative methods.14, 15 Of the other five studies, two involved both analysis of secondary data and a survey,16, 17 one was based on a retrospective case series18 and two were survey based.19, 20 Cohort sizes ranged from 10 to 76 participants. The themes extracted from the papers were: (1) rationale for using genetic counsellors to provide clinical care, (2) appropriate roles and responsibilities for genetic counsellors and (3) types of conditions that could be included in the genetic counsellor caseload.

Table 1 Table of included papers

The education and training of the genetic counsellors who were the focus of the studies was not mentioned in all papers. In the US papers, Hannig et al16 stated that genetic counsellors were licensed in the US state in which the study took place, whereas Powell et al20 and Hines et al15 studied members of the NSGC. It can therefore be assumed that the majority of the genetic counsellors in those studies were educated via a Master’s programme in genetic counselling. Hodgson et al14 explained that in Australia genetic counsellors undertook a postgraduate diploma in genetic counselling and could be certified by submitting a portfolio of cases to the Board of Censors of the Human Genetic Society of Australasia (HGSA). In that study, five participants were trained as genetic counsellors and one was certified. Similarly, in another Australian study James et al19 recruited certified genetic counsellors and associate genetic counsellors. All 10 counsellors in the Australian study by Kromberg et al18 were HGSA certified but had a range of backgrounds; five were nurses. Kromberg et al17 described the education of genetic counsellors in South Africa: all undertake a Master’s degree in genetic counselling and are able to apply for registration as a genetic counsellor with the Health Professionals Council of South Africa.

Rationale for genetic counsellors to provide clinical care

Authors stated that there was a need for genetic counsellors to be utilised to provide care because the number of patients seeking genetic health care was growing rapidly and the numbers of available medical geneticists could not cope with the demand;16 the increased demand for genetic counsellors was also related to increase in the complexity of cases and the number of laboratory test that were available, for which informed consent was necessary.16 Related to this point, Kromberg et al17 suggested that the role of the genetic counsellor would expand further, as pre- and post-test counselling was essential to accompany the increasing number of tests available, particularly for presymptomatic tests. It was claimed that genetic counsellors had more available clinical time than medical geneticists and consultations with genetic counsellors were therefore less pressured.16 Powell et al20 stated that the skills of the genetic counsellor were useful in public health settings, citing involvement in administering newborn screening programmes as an example. However, with regard to the value placed on genetic counsellors in some settings, it may be significant that the genetic counsellors in the study by Hannig et al16 were only allocated clinical space on a day it was not required by others and were unable to charge for their services. This could be important in a health-care system placed on insurance, such as the United States where that study was set.

Appropriate roles and responsibilities for genetic counsellors

Some authors described the activities undertaken by genetic counsellors in the clinical environment. These included family history taking,16, 19 pedigree drawing,19 risk assessment,16, 19 discussion of natural history of the condition,16 psychosocial impact of the diagnosis,19 provision of patient education,15, 18, 19 discussion of options,16 addressing ethical issues,15 making a psychosocial assessment16 and providing psychosocial support.15 Other responsibilities perceived to be appropriate for genetic counsellors included providing professional and public education18, 20 and conducting newborn screening programmes.20

Some authors mentioned roles that were not considered appropriate for genetic counsellors to undertake: Hannig et al16 expressly stated that examination and management of complex cases was outside the role. However, James et al19 found that some respondents did appear to be conducting clinical examinations. The extent to which this happened varied according to the work setting, as 9% of those working in main units, 20% of those in metro outreach clinics and 42% of those in rural outreach communities said they did clinical examinations, but this depended upon the condition or was performed in consultation with a medical geneticist. In an Australian study,18 the authors did not explicitly state that diagnosis was not undertaken by genetic counsellors, but did say that the reason that 20% of cases were seen by medical geneticists alone was because those cases required diagnostic input. Kromberg et al17 did not indicate that there were roles that should not be undertaken by genetic counsellors in South Africa, but did stress that emphasis on the prior experience of the counsellor should be considered.

Other authors took a different approach to analysis of roles. For example, in the study of prenatal genetic counselling, Hodgson et al14 described the counsellors providing information on the screening test, diagnostic testing, test procedure, risk of miscarriage, possible results and the nature of the decisions to be made by parents. In the same study the interactions between client and counsellor were designated as: risk communication, decision making dialogue and discourse on abortion. Somewhat similarly, Hines et al15 organised the responses of their participants into domains labelled information provision, reproductive decision making, psychosocial support and addressing ethical issues. The counsellors in that study offered presymptomatic testing for Huntington Disease, and did express the view that in some ways their service differed from other genetic counselling, for example, they felt that they were at times more directive in the context of counselling for Huntington disease.

Types of conditions that could be included in the genetic counsellor caseload

It was stated that genetic counsellors could provide care for families affected by or concerned about the following conditions: familial cancer,16, 17, 18, 19, 20 neurodegenerative conditions16 (including offering presymptomatic testing), chromosomal abnormalities16, 17, 18, 19, 20 (including the sex chromosomes18, 20), multiple miscarriage16, 17 and single-gene disorders18, 20 including haemoglobinopathy,16, 17 cystic fibrosis,16, 17, 18, 19 metabolic disorders,17, 19 neurofibromatosis,17, 18 muscular dystrophy,17, 18 haemachromatosis19 and Huntington disease.15, 17, 19 Counselling for neural tube defect,18, 19 advanced maternal age17, 18, 20 or abnormal prenatal screening results17, 20 were also explicitly mentioned by several authors.

Of interest, Hannig et al16 stated that the diagnosis should be known in cases of cystic fibrosis, neurogenetic conditions, endocrine disorders and sex chromosome abnormalities. This seems to contradict the claims of Powell et al,20 who cite cases of developmental delay as suitable for counselling by genetic counsellors, and Kromberg et al17 who cite general ‘fetal abnormality’ cases as suitable for genetic counsellor management.

Discussion

To ensure rigour, this review was conducted according to the stringent criteria recommended by the Centre for Reviews and Dissemination.11 The selection of material for inclusion and the quality assessment were conducted independently by at least two authors. However, we did not search for studies that had not been published in peer-reviewed journals, and there may be unpublished data that could have contributed to our understanding of this topic.

Both the Council of Europe21 and the Organisation for Economic Co-operation and Development22 recommendations on genetic testing emphasise that those considering testing must be provided with relevant information to enable them to give informed consent, and that people providing genetic counselling to accompany testing must have the required educational preparation and training. These points are consistent with the recommendations made by Kariainen et al23 in a document produced as part of the EuroGentest project that genetic counselling within the context of genetic testing must be delivered by a person trained to provide it. In a recent survey of members of the NSGC,24 73% of the members who responded had completed a Master’s degree in genetic counselling, whereas the majority of respondents to a similar survey for the Australasian Society of Genetic Counsellors25 had a graduate diploma (41%) or a Master’s degree (31%). The majority of genetic counsellors in the studies included in this review therefore appear to have been educated at postgraduate level via a specific genetic counselling programme, and all worked in countries where the opportunity for professional registration or certification existed. This confirms the European Board of Medical Genetics stance that education in genetic counselling or genetic nursing at Master’s degree level is essential to prepare professionals for practice.4

Hannig et al16 suggested that the increases in genetic tests, the concurrent need for genetic counselling to accompany those tests and the limitation to the numbers of medical geneticists to see clients has emphasised the need for genetic counsellors to be included in the team providing specialist genetic health-care services. This is in keeping with the standards of genetic counsellor practice in Europe3 that have been adopted by the European Board of Medical Genetics and the recommendations for genetic testing practice23 accepted by the ESHG, which state that genetic counselling should accompany genetic testing. However, it should be noted that none of the studies in this review were conducted in Europe, and this is an area where research is urgently needed to ensure that genetic counsellor roles are appropriate for this different cultural context.

Although there is general agreement about the core component of the role of the genetic counsellor across studies, the inclusion of a clinical examination of the consultant for diagnostic purposes is included in only one study.19 This appears to be controversial, as diagnosis or management of complex cases by genetic counsellors is specifically excluded in another study.16 It is possible that conflicting views about clinical examination arise owing to the differences in professional backgrounds of genetic counsellors: those who are also nurses may be trained in some examination skills and feel more confident in performing these. The study in which these skills were included was conducted in Australia, where a proportion of genetic counsellors have nursing backgrounds18 and where those in rural or remote locations may be expected to perform examinations. Diagnostic activities based on clinical examination are not mentioned in the European core competencies for genetic counsellors, however, it is clear that genetic counsellors utilise a range of documented evidence to perform genetic diagnoses to provide counselling. For example, a genetic counsellor would use the family history and a report signifying a BRCA1 mutation in an affected family member to make a diagnosis of familial breast and ovarian cancer and counsel the consultant accordingly.

The work of several authors in the area of health psychology has indicated that when an individual is faced with a health threat, adjustment to their circumstances is supported by expression of their emotional responses to the situation.26 This would seem to be consistent with the aspect of the genetic counsellor role that states it is based on an empathic client-centred approach.3 Enabling and inviting emotional expression could therefore facilitate adaptation and support effective decision making in the context of genetic risk. Roles included in this review include making a psychosocial risk assessment and offering psychosocial support. However, Roter et al27 identified four general styles of counsellor behaviour. These were clinical teaching (used by 31%), psycho-educational teaching (27%), supportive counselling (33%) and psychosocial counselling (14.9%). Those who used the first three models spoke at least five times as frequently as clients during simulated genetic counselling sessions, whereas even counsellors who utilised a psychosocial counselling model spoke at least four times as often as their clients, indicating that the consultation was highly counsellor oriented. One of the limitations of this study was the use of simulated, rather than genuine clients, and this may have affected both client and counsellor behaviour

The results of this review are interesting when compared with the findings of Ellington et al,28 who analysed the content and personal interaction of genetic counselling sessions concerning either prenatal diagnosis or familial cancer risk. The authors found that counsellors spent more time during the session focussing on enabling their clients to express emotional responses (25.49% of the total time) than they did supporting cognitive processing of the information provided (4.23% of the total time). However, the authors conclude that both responsiveness to client emotion and enabling cognitive processing are necessary to enable clients to process information provided and enable them to use it effectively in decision making. The predominance of the ‘teaching model’ within genetic counselling is certainly confirmed by the studies described above.27, 28 This may indicate that genetic counsellors are more comfortable with the ‘information giving’ aspects of their role than they are with eliciting client concerns or providing psychological care. However, as indicated by authors such as Lepore et al,26 this focus on information giving may not be optimal in supporting patients to make decisions relevant to their health care.

Although McCarthy Veach et al29 have suggested that the model of health care offered by the genetic counselling practice is somewhat unique, Smets et al30 argue that genetics specialists have similar ethos to health professionals operating outside the genetic speciality, and face similar challenges in engaging clients, eliciting the client’s agenda and facilitating understanding of relevant concepts. The authors conclude that rather than claim unique skills and approaches, genetic specialists could learn from research undertaken on shared decision making and client/professional communication outside the field.

The findings of this systematic review indicate that where genetic counsellors are utilised in specialist genetic settings, they undertake a significant workload associated with direct patient care and this appears to be acceptable to patients. Notwithstanding that limitation, with the increasing burden on genetic services generally, the results of this review could be used to argue for the increased use of genetic counsellors in countries where they are under-utilised. In addition, the roles undertaken by genetic counsellors in specialist genetic settings could be adapted to integrate genetic counsellors into multi-disciplinary teams in other specialisms.